VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
NTRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NTRANatera, Inc.
$309.93$44.4B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNTRABalance Sheet

Natera, Inc. (NTRA) Balance Sheet

14Y historyFree accessUpdated daily

The balance sheet strengthened with a $1.0B equity raise, reducing debt-to-equity from 0.55 in 2024Q1 to 0.13 in 2026Q2, while cash of $1.1B covers total debt of $238.5M by 4.6 times.

NTRA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Total Current Assets1.66B1.5B1.38B1.26B1.21B1.09B862.66M523.17M240.52M180.63M174.12M250.73M106.48M49.11M9.01M
Cash & Short-Term Investments1.09B1.08B968.28M878.98M898.39M914.28M737.27M440.99M153.87M118.87M146.12M230.53M87.18M30.5M5.76M
Cash Only1.09B1.08B945.59M642.1M466.09M84.39M48.67M61.93M46.41M12.62M15.26M28.95M87.18M30.5M5.76M
Short-Term Investments0022.69M236.88M432.3M829.9M688.61M379.06M107.46M106.25M130.86M201.59M000
Accounts Receivable421.97M296.53M314.17M278.29M244.38M122.07M78.56M53.35M62.22M44.09M13.4M5.86M5.94M6.63M1.31M
Days Sales Outstanding47.9546.9367.5893.83108.7571.2473.3464.4188.1576.2922.5211.2413.6243.8833.61
Inventory80.35M68.44M44.74M40.76M35.41M26.91M20.03M12.39M13.63M9M6.41M8.09M11.54M10.65M1.6M
Days Inventory Outstanding27.6130.8224.2425.2228.3230.8535.9125.7829.9723.5317.2726.1853.74104.3152.3
Other Current Assets65.13M55.83M48.63M60.52M33.63M228K187K55K4.6M59K1.09M901K503K150K340K
Total Non-Current Assets998.55M1.01B284.92M183.15M182.66M143.35M69.49M59.49M27.65M33.99M36.56M14.51M17.15M10.62M4.28M
Property, Plant & Equipment447.25M349.73M248.19M167.75M164.33M124.53M54.75M47.01M24.34M29.67M32.29M12.71M14.57M9.79M4.07M
Fixed Asset Turnover7.20x6.59x6.84x6.45x4.99x5.02x7.14x6.43x10.59x7.11x6.72x14.98x10.93x5.63x3.50x
Goodwill141.1M141.07M0000000000000
Intangible Assets360.2M373.71M0000000000000
Long-Term Investments00000000000000207K
Other Non-Current Assets49.99M36.9M36.72M15.4M18.33M18.82M14.74M12.48M3.32M4.32M4.28M1.8M2.57M825K-1
Total Assets2.66B2.51B1.66B1.44B1.39B1.24B932.15M582.66M268.17M214.61M210.68M265.24M123.62M59.72M13.29M
Asset Turnover1.13x0.92x1.02x0.75x0.59x0.51x0.42x0.52x0.96x0.98x1.03x0.72x1.29x0.92x1.07x
Asset Growth %167.67%51.02%15.19%3.39%12.78%32.65%59.98%117.27%24.96%1.87%-20.57%114.56%106.99%349.28%-
Total Current Liabilities553.2M441.23M344.05M307.27M310.5M218.96M199.05M179.87M113.98M105.56M96.42M80.47M29.87M23.57M138.9M
Accounts Payable75.15M33.16M34.92M15M31.15M27.21M8.1M8.6M14.59M8.53M11.48M7.33M8.87M11.3M4.5M
Days Payables Outstanding21.114.9318.929.2824.9231.1914.5117.932.0622.330.923.7241.28110.62147.41
Short-Term Debt80.29M80.32M80.36M80.4M80.35M50.05M50.05M50.12M50.15M50.11M49.62M42.09M2.34M1.84M131.75M
Deferred Revenue (Current)124.11M24.91M19.75M16.61M10.78M7.4M50.13M56.02M4.13M1.42M574K144K112K970K314K
Other Current Liabilities22.82M102.11M73.39M69.1M62.96M58.15M47.74M25.5M22.68M19.04M22.39M12.24M8.31M3.71M952K
Current Ratio3.00x3.39x4.00x4.10x3.90x4.99x4.33x2.91x2.11x1.71x1.81x3.12x3.56x2.08x0.06x
Quick Ratio2.85x3.24x3.87x3.96x3.79x4.87x4.23x2.84x1.99x1.63x1.74x3.02x3.18x1.63x0.05x
Cash Conversion Cycle54.4562.8272.9109.77112.1670.994.7372.2986.0577.528.8913.726.0737.56-61.51
Total Non-Current Liabilities282.8M354.4M121.27M369.1M378.23M364.23M246.86M124.07M122.03M83.64M7.79M0265.09M207.66M0
Long-Term Debt000282.94M281.65M280.39M202.49M73.66M73.36M73.06M0024.47M22.46M0
Capital Lease Obligations510.88M118.47M96.59M67.03M76.58M61.04M21.25M26.3M0000000
Deferred Tax Liabilities111.8M110.39M0000000000000
Other Non-Current Liabilities122.95M108.47M7.84M001.48M320K310K8.61M10.57M7.79M0240.61M185.2M0
Total Liabilities836M795.62M465.31M676.37M688.73M583.18M445.92M303.94M236.01M189.2M104.2M80.47M294.96M231.23M138.9M
Total Debt223.37M214.38M187.12M441.99M446.22M397.23M281.09M155.81M123.51M123.18M49.62M42.09M26.81M24.31M131.75M
Net Debt-868.14M-861.76M-758.47M-200.1M-19.87M312.85M232.43M93.89M77.1M110.56M34.37M13.14M-60.36M-6.19M125.99M
Debt / Equity0.12x0.13x0.16x0.58x0.63x0.61x0.58x0.56x3.84x4.85x0.47x0.23x---
Debt / EBITDA-0.95x-----------4.61x--
Net Debt / EBITDA3.68x------------10.38x--
Interest Coverage-24.51x-64.89x-16.76x-33.38x-57.68x-55.72x-14.23x-10.49x-10.94x-31.56x-186.96x-19.05x0.16x-2.11x-
Total Equity1.82B1.71B1.2B765.33M705.74M653.3M486.24M278.71M32.16M25.42M106.48M184.76M-171.34M-171.51M-125.61M
Equity Growth %175.05%43.25%56.2%8.44%8.03%34.36%74.46%766.58%26.54%-76.13%-42.37%207.84%0.1%-36.54%-
Book Value per Share12.7112.529.586.667.177.216.004.010.560.472.063.87-4.67-4.68-40.18
Total Shareholders' Equity1.82B1.71B1.2B765.33M705.74M653.3M486.24M278.71M32.16M25.42M106.48M184.76M-171.34M-171.51M-125.61M
Common Stock14K14K12K11K11K10K9K8K7K6K5K5K1K1K1K
Retained Earnings-2.93B-2.78B-2.57B-2.38B-1.94B-1.39B-929.32M-699.17M-574.53M-446.38M-345.85M-250.08M-179.81M-174.66M-137.55M
Treasury Stock000000000000000
Accumulated OCI-108K-258K-344K-3.08M-16.36M-2.29M4.26M919K-552K-766K-725K-1.42M000
Minority Interest000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Persistent negative operating margins

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Strengthens on Equity Raise

Total assets grew 80% from $1.5B in 2024Q1 to $2.7B in 2026Q2, driven by a $1.0B equity raise in late 2025, as reported in financial statements, while liabilities rose only 24%.

The balance sheet has expanded rapidly, but the composition reveals a strategic shift: equity surged from $794M to $1.8B, while total debt was reduced from $440M to $238M. This deleveraging, combined with a growing cash pile, suggests management prioritized financial flexibility over maximizing returns on equity. The trajectory indicates a deliberate move to fund growth without relying on debt markets, which is prudent given the company's ongoing operating losses.

Leverage Halved, Refinancing Risk Minimal

Debt-to-equity fell from 0.55 in 2024Q1 to 0.13 in 2026Q2, with total debt down to $238.5M, per reported figures, while cash of $1.1B covers debt over 4.6 times.

The dramatic reduction in leverage appears strategic, likely funded by the equity raise, and positions the company to withstand operational volatility. With a current ratio of 3.0 and minimal debt maturities, refinancing risk is low. However, the low leverage also implies a conservative capital structure that may dilute returns if growth stalls, but it provides a cushion against the persistent negative operating margins.

Asset Base Shifts to Tangible Expansion

PP&E nearly doubled from $180M in 2024Q1 to $447M in 2026Q2, while goodwill emerged at $141M in 2025Q4, as per balance sheet data, indicating investment in lab capacity and an acquisition.

The sharp increase in PP&E reflects significant capital expenditure on laboratory automation and capacity, aligning with the reported capex spike in 2026Q2. The appearance of goodwill suggests an acquisition, which introduces potential impairment risk if growth expectations are not met. The asset mix is becoming more asset-heavy, which could pressure margins if utilization does not scale, but it also signals a commitment to long-term operational capacity.

Equity Bolstered by Dilutive Raise

Equity jumped from $794M to $1.8B over ten quarters, driven by a $1.0B capital raise, while retained earnings remained deeply negative at -$2.9B, as reported in financial statements.

The equity expansion is primarily from external financing, not retained earnings, which remain deeply negative due to cumulative losses. This suggests the company is relying on shareholder capital to fund operations, and the dilution from the raise may pressure future EPS. However, the strong cash position provides a runway to achieve profitability without immediate financing needs, though the negative retained earnings highlight the long road to book value accretion.

Cash Buffer Ample Despite Operating Losses

Cash and equivalents stood at $1.1B in 2026Q2, up from $814M in 2024Q1, with a current ratio of 3.0, per balance sheet data, providing a multi-year runway against operating losses.

The liquidity position is robust, with cash covering over four times total debt and a current ratio well above 1.0. Given the TTM net loss of approximately -$67M per quarter, the cash pile appears sufficient to fund operations for several years without external financing. This buffer is critical as the company continues to invest heavily in growth, but investors should monitor the burn rate relative to cash, especially if revenue growth decelerates.

Goodwill and SBC Distort Balance Sheet

Goodwill of $141M appeared in 2025Q4, and stock-based compensation of $103M in 2026Q2 exceeds operating cash flow, as per reported figures, suggesting potential overstatement of asset quality and cash generation.

The sudden appearance of goodwill indicates an acquisition that may carry impairment risk if the acquired business underperforms. Additionally, the heavy use of stock-based compensation, which is non-cash but dilutive, inflates equity and masks the true economic cost of operations. Investors should adjust for SBC to assess the real cash burn and the sustainability of the balance sheet strength, as the reported equity may overstate the company's intrinsic value.

NTRA — Frequently Asked Questions

Quick answers to the most common questions about buying NTRA stock.

What are the total assets of Natera, Inc. (NTRA)?

As of 2025, Natera, Inc. (NTRA) had total assets of $2.51B including $1.50B in current assets.

How much debt does Natera, Inc. (NTRA) have?

Natera, Inc. (NTRA) carries total debt of $214.4M, offset by $1.08B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Natera, Inc.?

Natera, Inc. (NTRA) has total shareholders' equity (book value) of $1.71B ($12.52 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Natera, Inc.'s current ratio and liquidity?

Natera, Inc. (NTRA) reported a current ratio of 3.39x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.